Digest ++
Digest ++, licence 80095207: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- VSC Leader Source Products Co. Ltd.
- NPN or DIN-HM
- 80095207
- Status
- Active licence
- Licence date
- 5 November 2019
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| bêta-fructofuranosidase Source : Aspergillus niger - En entier | 2860.0 FCC INVU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 30.0 mg | Not calculated |
| bêta-fructofuranosidase Source : Aspergillus niger - En entier | 20.0 mg | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 3500.0 FCC CU | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Acts as a digestive aid.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use. Stop use if gastro-intestinal disturbance and/or hypersensitivity/allergy occur. Stop use if hypersensitivity/allergy, nausea, vomiting or diarrhoea occur.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have gastrointestinal lesions/ulcers or are having surgery. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are taking anticoagulant agents, anti-inflammatory agents or antibiotics. Consult a Health care professional/health care practitioner/doctor/physician prior to use if you have diabetes.
Source
Official Health Canada record, licence 80095207
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.